Going screenless proves you can afford to be intentionally inefficient.
We’re ready for some bad jokes during Google’s celebrity-packed live show.
We’re talking offline Gemini, proactive AI suggestions, better GPS maps, insulin resistance trends, and a $50 price hike.
Its recent attempts to shore up privacy don’t seem to be convincing skeptics.
Living an optimized, self-quantified life can get a little out of hand.
An advisory panel, stacked with RFK Jr.’s pro-peptide appointees, has voted to add BPC-157 and KPV to the bulk compounding list. This is despite FDA staff clinicians stating that there’s no convincing evidence. Central to the argument is whether allowing compounding will curtail the gray market or expose the public to unnecessary risk. Internally screaming.
The watches sport a new chip, bigger batteries, and new health metrics. But the updates come with another price hike.
Leonardo Del Vecchio, president of Ray-Ban and chief strategy officer at EssilorLuxottica, posted these to his Instagram story. The first is a picture of an activist ad plastered over an actual Meta Glasses ad… and the second is Del Vecchio saying, “If we can’t laugh about it why should anyone trust us?”
Legend has it that we have smart home security cameras and smartphones to thank for discovering the Seattle-based treasure that is Jimothy. At least this modern cryptid doesn’t appear to be AI slop. Happy Friday.
